Clinical signs and symptoms predicting influenza infection - PubMed (original) (raw)
Clinical signs and symptoms predicting influenza infection
A S Monto et al. Arch Intern Med. 2000.
Abstract
Background: New antiviral drugs are available for the treatment of influenza type A and type B infections. In clinical practice, antiviral use has rarely been guided by antecedent laboratory diagnosis. Defined clinical predictors of an influenza infection can help guide timely therapy and avoid unnecessary antibiotic use.
Objective: To examine which clinical signs and symptoms are most predictive of influenza infection in patients with influenza-like illness using a large data set derived from clinical trials of zanamivir.
Methods: This analysis is a retrospective, pooled analysis of baseline signs and symptoms from phase 2 and 3 clinical trial participants. It was conducted in mainly unvaccinated (mean age, 35 years) adults and adolescents who had influenza-like illness, defined as having fever or feverishness plus at least 2 of the following influenza-like symptoms: headache, myalgia, cough, or sore throat who underwent laboratory testing for influenza. Clinical signs and symptoms were evaluated in statistical models to identify those best predicting laboratory confirmation of influenza.
Results: Of 3744 subjects enrolled with baseline influenza-like symptoms, and included in this analysis, 2470 (66%) were confirmed to have influenza. Individuals with influenza were more likely to have cough (93% vs 80%), fever (68% vs 40%), cough and fever together (64% vs 33%), and/or nasal congestion (91% vs 81%) than those without influenza. The best multivariate predictors of influenza infections were cough and fever with a positive predictive value of 79% (P<. 001). The positive predictive value rose with the increase in the temperature at the time of recruitment.
Conclusion: When influenza is circulating within the community, patients with an influenza-like illness who have both cough and fever within 48 hours of symptom onset are likely to have influenza and the administration of influenza antiviral therapy may be appropriate to consider. Arch Intern Med. 2000;160:3243-3247.
Comment in
- Clinical signs and symptoms predicting influenza infection.
Hak E, Moons KG, Verheij TJ, Hoes AW. Hak E, et al. Arch Intern Med. 2001 May 28;161(10):1351-2. doi: 10.1001/archinte.161.10.1351. Arch Intern Med. 2001. PMID: 11371268 No abstract available.
Similar articles
- Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.
Kaiser L, Keene ON, Hammond JM, Elliott M, Hayden FG. Kaiser L, et al. Arch Intern Med. 2000 Nov 27;160(21):3234-40. doi: 10.1001/archinte.160.21.3234. Arch Intern Med. 2000. PMID: 11088083 - Symptomatic predictors of influenza virus positivity in children during the influenza season.
Ohmit SE, Monto AS. Ohmit SE, et al. Clin Infect Dis. 2006 Sep 1;43(5):564-8. doi: 10.1086/506352. Epub 2006 Jul 12. Clin Infect Dis. 2006. PMID: 16886147 - Effect of zanamivir on duration and resolution of influenza symptoms.
Monto AS, Moult AB, Sharp SJ. Monto AS, et al. Clin Ther. 2000 Nov;22(11):1294-305. doi: 10.1016/s0149-2918(00)83026-x. Clin Ther. 2000. PMID: 11117654 - Zanamivir: a review of its use in influenza.
Dunn CJ, Goa KL. Dunn CJ, et al. Drugs. 1999 Oct;58(4):761-84. doi: 10.2165/00003495-199958040-00016. Drugs. 1999. PMID: 10551442 Review. - Neuraminidase inhibitors: zanamivir and oseltamivir.
McNicholl IR, McNicholl JJ. McNicholl IR, et al. Ann Pharmacother. 2001 Jan;35(1):57-70. doi: 10.1345/aph.10118. Ann Pharmacother. 2001. PMID: 11197587 Review.
Cited by
- Two-Stream Convolutional Neural Networks for Breathing Pattern Classification: Real-Time Monitoring of Respiratory Disease Patients.
Park J, Nguyen T, Park S, Hill B, Shadgan B, Gandjbakhche A. Park J, et al. Bioengineering (Basel). 2024 Jul 12;11(7):709. doi: 10.3390/bioengineering11070709. Bioengineering (Basel). 2024. PMID: 39061791 Free PMC article. - Symptom propagation in respiratory pathogens of public health concern: a review of the evidence.
Asplin P, Mancy R, Finnie T, Cumming F, Keeling MJ, Hill EM. Asplin P, et al. J R Soc Interface. 2024 Jul;21(216):20240009. doi: 10.1098/rsif.2024.0009. Epub 2024 Jul 24. J R Soc Interface. 2024. PMID: 39045688 Free PMC article. Review. - The Detection of Influenza Virus Before and During the COVID-19 Pandemic in Cameroon.
Monamele GC, Tsafack DT, Bilounga CN, Njankouo Ripa M, Nsangou Yogne C, Munshili Njifon HL, Nkom F, Tamoufe U, Esso L, Koro Koro F, Perraut R, Njouom R. Monamele GC, et al. Influenza Other Respir Viruses. 2024 May;18(5):e13313. doi: 10.1111/irv.13313. Influenza Other Respir Viruses. 2024. PMID: 38757747 Free PMC article. - Lateral Flow Biosensor for On-Site Multiplex Detection of Viruses Based on One-Step Reverse Transcription and Strand Displacement Amplification.
Lu X, Ding K, Fang Z, Liu Y, Ji T, Sun J, Zeng Z, He L. Lu X, et al. Biosensors (Basel). 2024 Feb 17;14(2):103. doi: 10.3390/bios14020103. Biosensors (Basel). 2024. PMID: 38392022 Free PMC article. - Health equity, care access and quality in headache - part 1.
Tana C, Raffaelli B, Souza MNP, de la Torre ER, Massi DG, Kisani N, García-Azorín D, Waliszewska-Prosół M. Tana C, et al. J Headache Pain. 2024 Jan 29;25(1):12. doi: 10.1186/s10194-024-01712-7. J Headache Pain. 2024. PMID: 38281917 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical